Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) (Q55054420)
scientific article published on June 2, 2011
Language:
(P31) (Q13442814)
(P50) (Q86692954)
(Q111584599)
(Q45343075)
(P304) 618-625
(P407) (Q1860)
(P433) 7
(P478) 10
(P577) Thursday, June 2, 2011
(P921) (Q42824827)
(Q269829)
(Q50430493)
(P953) https://api.elsevier.com/content/article/PII:S1474442211701089?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1474442211701089?httpAccept=text/plain
(P1433) (Q15755067)
(P1476) "Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)" (language: en)
(P2093) Emanuela Keller
Andy Molyneux
Andreas Raabe
Isabel Wanke
Doris Bach
Aline Frey
Angelina Marr
Sébastien Roux
Neal Kassell
R. Loch Macdonald
Randall T. Higashida
(P2860) (Q57314835)
(Q51033909)
(Q39826081)
(Q30454281)
(Q30445777)
(Q37732612)
(Q37246038)
(Q48485979)
(Q46668706)
(Q37238204)
(Q42908270)
(Q73149989)
(Q29618624)
(Q78745323)
(Q40791071)
(Q34928426)
(Q37834294)
(Q28300542)
(Q48386501)
(Q37217250)
(Q37344132)
(Q46240492)
(Q35010436)
(Q48367825)
other details
description scientific article published on June 2, 2011

External Links